← Browse by Condition
Medical Condition
differentiated thyroid cancer
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT05783323 Phase 2
Recruiting
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Enrollment
13 pts
Location
United States
Sponsor
Children's Hospital of Philade...
NCT03757637
Recruiting
Compare the Effects of NLSCP and Interactive ICT Supported HAP on Differentiate Diagnosed Thyroid Cancer Patients
Enrollment
380 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...